Nanotechnology

Cambridge, GB · 2 known investors

Abselion develops instruments and assay kits for quantifying biologics such as proteins, viral vectors, and other biomolecules used in research, development, and bioprocessing. The company's Amperia platform uses electrochemical detection technology to enable reliable measurement workflows for teams working in biologics innovation.